This Genome Watch highlights how the integration of genomic surveillance with epidemiological or clinical data can help understand pathogen transmission and improve public health interventions for infectious disease control.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Colijn, C. et al. The need for linked genomic surveillance of SARS-CoV-2. Can. Commun. Dis. Rep. 48, 131–139 (2022).
Gorzynski, J. et al. Epidemiological analysis of Legionnaires’ disease in Scotland: a genomic study. Lancet Microbe 3, E835–E845 (2022).
Czech-Sioli, M. et al. Integration of sequencing and epidemiologic data for surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections in a tertiary-care hospital. Clin. Infect. Dis. 76, e263–e273 (2023).
Tansarli, G. S. et al. Genomic reconstruction and directed interventions in a multidrug-resistant Shigellosis outbreak in Seattle, WA, USA: a genomic surveillance study. Lancet Infect. Dis. 23, 740–750 (2023).
Goig, G. A. et al. Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study. Lancet Microbe 4, E506–E515 (2023).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barton, A., Colijn, C. Genomic, clinical and immunity data join forces for public health. Nat Rev Microbiol 21, 639 (2023). https://doi.org/10.1038/s41579-023-00965-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41579-023-00965-4
